Delivery Order SPE2DB25D3018-SPE2DB25FUYGN
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 15 mg nasal sprays, a medication used for acute seizure management. This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,373.64 and an ultimate completion date of August 11, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 4, 2025. This firm fixed-price contract, issued on August 1, 2025, represents a non-set-aside competitive award with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, valued at $2,257.08 under firm fixed pricing. This delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,173.67 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance completion required by August 15, 2025. This firm fixed-price contract, awarded on August 14, 2025, represents a non-set-aside competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $7,354.61. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,114.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 15 mg nasal sprays. The contract employs firm fixed-price pricing and is scheduled for completion by August 15, 2025. This non-competitive delivery order will be fulfilled from the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYGNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Valtoco 15 mg nasal sprays, valued at $2,372.64. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The contract carries no set-aside designation and reflects AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency's pharmaceutical supply chain operations, with completion scheduled by August 19, 2025. Valtoco, a nasal spray formulation used for acute seizure management, represents the type of specialized medication that AmerisourceBergen routinely distributes through its DLA prime vendor contract to support military and veteran healthcare systems globally. The company's comprehensive contract portfolio with DLA demonstrates its role as a critical supplier of brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/18/25 |